Trial Profile
Efficacy of the bimonthly treatment regimen with intravitreal Aflibercept in patients with Neovascular Age-Related Macular Degeneration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2016
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 08 Dec 2016 New trial record